CureVac, eTheRNA also have early-stage mRNA vaccines in the works

The slowdown in biopharma financings and M&A has provided some buysiders a welcome relief from the breakneck pace of the past year and a half, and with many companies’ coffers full, the

DISEASE CATEGORY: Infectious disease
INDICATION: Malaria Researchers at NIH identified a mAb targeting CSP, the dominant protein on the Plasmodium falciparum sporozoite surface, that

BioCentury’s roundup of translational news